Riya Baibhawi

Lotions, Sunscreens Linked To Hormonal Disruptions In Children: Study

Child care

A recent study by George Mason University College of Public Health has highlighted a concerning correlation between the use of personal care products and elevated levels of phthalates in young <span>children</span>. Phthalates, chemicals used to increase the flexibility and durability of plastics, are also commonly found in lotions, hair oils, conditioners, and sunscreens. The study’s findings suggest these chemicals may pose potential risks to children's development during critical growth phases.

Led by Professor Michael S. Bloom, the study involved medical data from 630 children aged four to eight across ten sites in the United States. Each child underwent a clinical examination and urinalysis, while parents provided detailed information about their child’s sociodemographic background and the specific personal care products used within 24 hours before the examination.

The results revealed a significant association between the recent use of various skin care products and higher concentrations of phthalates and their replacements. Notably, the study found variations in the relationship between product use and phthalate levels based on the children’s racial and ethnic identities and sex assigned at birth. This indicates that different skin care routines may lead to different exposure levels of these endocrine-disrupting chemicals.

"The study underscores the need to understand how different personal care products contribute to endocrine-disrupting chemical exposure in children," said Bloom. "These findings can guide policy decisions and help parents make informed choices about the products they use on their children."

<h2>Natural Skin Care For <span rel="noindex">Toddlers</span> And Children</h2>To minimize exposure to harmful chemicals, consider these natural skin care alternatives:

- <strong>Gentle Cleansing</strong>: Use plain water or mild, homemade soap with natural ingredients like olive oil and coconut oil.

- <strong>Moisturizing</strong>: Apply natural oils such as coconut oil or almond oil, which are gentle and free of synthetic additives.

- Sun Protection: Dress children in protective clothing and hats, and seek shade during peak sun hours to avoid the need for chemical sunscreens.

- <strong>Bathing Frequency</strong>: Limit baths to avoid stripping natural oils from the skin; use lukewarm water and keep baths brief.

- <strong>Diet and Hydration</strong>: Maintain a balanced diet rich in fruits and vegetables and ensure adequate hydration to support healthy skin from within.

Health Conditions A-Z

health

Health news

toddlers

hormonal disruptions in children

children skincare product research

children

Poor Mental Health As Child Limits Capacity To Work In Later Life

What Causes And What Doesn't Causes Miscarriages?

High Cholesterol Linked To Longer Life Spans In This Blue Zone

Health News

Why Does Sleeping Become Harder As You Age?

High-Fiber Healthy Drinks You Should Try

10 Dumbbell Exercise Variations For Upper-Body Strength

A Parent’s Guide To Pets: Important Points To Consider For Your Child’s Health

Food Anxiety Is Real – How Your Food Intake Affects Your Anxiety

World Osteoporosis Month: Ways To Strengthen Your Bones

Brain Exercises To Keep You Cognitively Sharp

Easy Recipes To Make When You Don’t Wish To Cook

Physical Signs Of High Cortisol

9 Healthy Plant-Based Protein Rich Dishes To Try

What Happens When You Have Low Blood Pressure?

Throw These Toxic Bathroom Items Away To Protect Your Health

This Is What Cricket Superstar Virat Kohli Eats In A Day

Signs You Are Experiencing Sensory Overload

Shoulder Exercises You Should Do For Defined Shoulders

Best Foods To Eat When You Are Fasting

​Ghee For Ayurveda: Why It Should Be A Part Of Your Diet​

Symptoms Of Ovarian Cancer You Should Know

Yoga Poses That Can Build Core Strength

Biotin-Rich Foods You Should Add To Your Diet

Unexpected Physical Signs Of Stress

Simple And Affective Guide To Stop A Panic Attack

Signs Of Heat Exhaustion In Children

10 Heart Symptoms You Shouldn't Ignore

Lower Your Cholesterol With These Foods

Food Myths You Should Stop Believing

Work Stressing You Out? Tips To Handle Toxic Workspaces

Looking To Gain Weight? High-Calorie Healthy Foods To Try

​Pomegranates Are A Must For Summer, Here’s Why​

​How Does Being A Night Owl Change Your Brain​

​Can Nightlights Affect Your Child’s Sleep​

How To Decide Whether You Should Do Cardio Or Strength Training?

Enjoying Hobbies As An Adult Is More Important Than You Realize

Screentime Matters For Parents Too, Here's How It Causes Issues

Why Should We Discard Expired Prescription Drugs?

Perks Of Having Home Plants For Your Health

Signs You Are Dealing With Depleted Mother Syndrome

Protein-Rich Fruit Smoothies You Must Try

Ways You Can Reach Out To Someone In A Mental Health Crisis

These Things Are Causing You To Lose Sleep

A recent study by George Mason University College of Public Health has highlighted a concerning correlation between the use of personal care products and elevated levels of phthalates in young children. Phthalates, chemicals used to increase the flexibility and durability of plastics, are also commonly found in lotions, hair oils, conditioners, and sunscreens. The study’s findings suggest these chemicals may pose potential risks to children's development during critical growth phases.Led by Professor Michael S. Bloom, the study involved medical data from 630 children aged four to eight across ten sites in the United States. Each child underwent a clinical examination and urinalysis, while parents provided detailed information about their child’s sociodemographic background and the specific personal care products used within 24 hours before the examination.The results revealed a significant association between the recent use of various skin care products and higher concentrations of phthalates and their replacements. Notably, the study found variations in the relationship between product use and phthalate levels based on the children’s racial and ethnic identities and sex assigned at birth. This indicates that different skin care routines may lead to different exposure levels of these endocrine-disrupting chemicals."The study underscores the need to understand how different personal care products contribute to endocrine-disrupting chemical exposure in children," said Bloom. "These findings can guide policy decisions and help parents make informed choices about the products they use on their children."Natural Skin Care For Toddlers And ChildrenTo minimize exposure to harmful chemicals, consider these natural skin care alternatives:- Gentle Cleansing: Use plain water or mild, homemade soap with natural ingredients like olive oil and coconut oil.- Moisturizing: Apply natural oils such as coconut oil or almond oil, which are gentle and free of synthetic additives.- Sun Protection: Dress children in protective clothing and hats, and seek shade during peak sun hours to avoid the need for chemical sunscreens.- Bathing Frequency: Limit baths to avoid stripping natural oils from the skin; use lukewarm water and keep baths brief.- Diet and Hydration: Maintain a balanced diet rich in fruits and vegetables and ensure adequate hydration to support healthy skin from within.

lotions, sunscreens linked to hormonal disruptions in children: study

Health and Me

Tanya Dutt

Longest Covid Infection Reported Lasted 505 Days Nonstop; What Are Persistent Infections?

Longest Covid Infection Reported Lasted 505 Days Nonstop

As Covid-19 Cases Spike In Hong Kong, Singapore; Is The Next Pandemic Wave Starting In Asia?

as covid-19 cases spike in hong; singapore, is the next pandemic wave starting in asia?

FDA Approves New COVID Vaccine But Not Everyone Qualifies

fda approves new covid vaccine but not everyone qualifies

Health & Wellness

Long COVID 'Brain Fog' Linked To Inflammation, Stress Markers: Study

long covid 'brain fog' linked to inflammation, stress markers: study

Covid Cases Surge In Singapore: What Do We Know About The New Variant On The Loose?

covid cases surge in singapore: what do we know about the new variant on the loose?

Can you imagine testing positive for <span>COVID-19</span> for more than 500 days- during lockdowns, vaccine distributions, new strains, and changing worldwide policies? It reads like the script of a dystopian thriller, but it's real and illustrates just how capricious this virus has proven to be, five years on from its initial outbreak.

As we step through 2025 with vaccines out there in plenty, rapid testing business as usual, and public health measures optimized, it's hard not to consider COVID-19 a chapter we're finally closing. But for a number of people, the virus wasn't an ordeal that lasted for a matter of weeks, but a long, persistent fight. One such example in the United Kingdom beat all known records: a man was infected with the virus for an incredible 505 days before his death, which stands as the longest confirmed <span>COVID-19 infection</span> to date.

British researchers have found what seems to be the longest-reported COVID-19 infection to date, an astonishing 505 days. The case of the unnamed patient with several chronic health conditions and a very compromised immune system highlights the nuance of how SARS-CoV-2 acts in immunocompromised patients.

The patient, who had tested positive for COVID-19 early in the year 2020, was infected for the rest of their life until they passed away in 2021 despite treatment interventions such as antiviral medication. This case has redefined what the global medical community knows about persistent COVID-19 infections and presented new avenues for research and better care for at-risk populations.

<h2>What Makes This Case And Persistent COVID-19 Different?</h2>

One of the most important differences to grasp is between "persistent" infection from COVID-19 and "Long COVID." While Long COVID is a term used for symptoms that persist after the virus has cleared from the body, persistent infection involves ongoing viral replication over time. The virus in this instance never actually leaves the body, which forms ongoing active infection instead of residual symptoms.

In this British case, all of the patient's over 50 PCR tests in 72 weeks returned positive, indicating a persistent, constant infection. This was reinforced by King's College London and Guy's and St Thomas' NHS Foundation Trust researchers through genomic sequencing that indicated it was the same strain evolving over time—not repeated reinfections.

This unusual case was one of many included in a larger study that was discussed at the European Congress of Clinical Microbiology and Infectious Diseases by infectious disease specialist Dr. Luke Blagdon Snell. The study looked at nine patients with long-term infections, all lasting at least eight weeks. These patients, whose immune systems were severely impaired due to illness such as HIV, cancer, or immunosuppressive drugs used after organ transplant, provided an unusual insight into what happens when the body is unable to respond with a normal immune response.

The typical length of infection in the nine patients was about 73 days. Prior to the identification of this record case, the longest-documented COVID-19 infection was 335 days long.

While unusual, these long-term infections create worries beyond the patients themselves. One of the scientists' biggest worries is that the virus, not having been contained by the body for so long, could mutate into new strains. Though none of the patients in this case—including one who had a 505-day infection—gave rise to a new variant of concern, genetic analysis did reveal mutations like those that occur in highly circulated variants.

"This doesn't say anything about a single patient. It says something about how the virus might evolve over time if left in a setting in which it's not eliminated," Dr. Snell stated.

Even after receiving antiviral medications such as remdesivir, the patient could not eliminate the infection, showing the insufficiency of existing treatments in certain high-risk groups. Among the nine patients analyzed, five survived with different recovery trajectories. Two cleared the virus without any medication, two were responsive to antiviral treatment, and one patient remained infected after 412 days at the last reported follow-up.

This unsettling volatility identifies the imperative for greater treatment options and care customization for immunocompromised individuals.

<h2>What This Means for People With Low Immunity?</h2>

Tens of millions of individuals across the globe have weakened immune systems—because of organ transplants, autoimmune conditions, or cancer treatments. The results from this study indicate an immediate call to maintain awareness in safeguarding these groups, particularly as pandemic measures loosened and mask mandates are all but gone.

This case not only illuminates the biological dynamics of COVID-19 but also serves as a reminder of the human narratives behind pandemic statistics. This patient existed, in a state of health most people shake off in a matter of days or weeks, for almost a year and a half—a grim reminder of the unpredictability of the virus and the strength of its victims.

covid-19

covid-19 infection

covid-19 2025 variant

longest covid infection

persistent covid case

new covid mutation

uk covid study

covid in immunocompromised

covid-19 latest news

Can you imagine testing positive for COVID-19 for more than 500 days- during lockdowns, vaccine distributions, new strains, and changing worldwide policies? It reads like the script of a dystopian thriller, but it's real and illustrates just how capricious this virus has proven to be, five years on from its initial outbreak.As we step through 2025 with vaccines out there in plenty, rapid testing business as usual, and public health measures optimized, it's hard not to consider COVID-19 a chapter we're finally closing. But for a number of people, the virus wasn't an ordeal that lasted for a matter of weeks, but a long, persistent fight. One such example in the United Kingdom beat all known records: a man was infected with the virus for an incredible 505 days before his death, which stands as the longest confirmed COVID-19 infection to date.British researchers have found what seems to be the longest-reported COVID-19 infection to date, an astonishing 505 days. The case of the unnamed patient with several chronic health conditions and a very compromised immune system highlights the nuance of how SARS-CoV-2 acts in immunocompromised patients.The patient, who had tested positive for COVID-19 early in the year 2020, was infected for the rest of their life until they passed away in 2021 despite treatment interventions such as antiviral medication. This case has redefined what the global medical community knows about persistent COVID-19 infections and presented new avenues for research and better care for at-risk populations.What Makes This Case And Persistent COVID-19 Different?One of the most important differences to grasp is between "persistent" infection from COVID-19 and "Long COVID." While Long COVID is a term used for symptoms that persist after the virus has cleared from the body, persistent infection involves ongoing viral replication over time. The virus in this instance never actually leaves the body, which forms ongoing active infection instead of residual symptoms.In this British case, all of the patient's over 50 PCR tests in 72 weeks returned positive, indicating a persistent, constant infection. This was reinforced by King's College London and Guy's and St Thomas' NHS Foundation Trust researchers through genomic sequencing that indicated it was the same strain evolving over time—not repeated reinfections.This unusual case was one of many included in a larger study that was discussed at the European Congress of Clinical Microbiology and Infectious Diseases by infectious disease specialist Dr. Luke Blagdon Snell. The study looked at nine patients with long-term infections, all lasting at least eight weeks. These patients, whose immune systems were severely impaired due to illness such as HIV, cancer, or immunosuppressive drugs used after organ transplant, provided an unusual insight into what happens when the body is unable to respond with a normal immune response.The typical length of infection in the nine patients was about 73 days. Prior to the identification of this record case, the longest-documented COVID-19 infection was 335 days long.What are Persistent Infections?While unusual, these long-term infections create worries beyond the patients themselves. One of the scientists' biggest worries is that the virus, not having been contained by the body for so long, could mutate into new strains. Though none of the patients in this case—including one who had a 505-day infection—gave rise to a new variant of concern, genetic analysis did reveal mutations like those that occur in highly circulated variants."This doesn't say anything about a single patient. It says something about how the virus might evolve over time if left in a setting in which it's not eliminated," Dr. Snell stated.Even after receiving antiviral medications such as remdesivir, the patient could not eliminate the infection, showing the insufficiency of existing treatments in certain high-risk groups. Among the nine patients analyzed, five survived with different recovery trajectories. Two cleared the virus without any medication, two were responsive to antiviral treatment, and one patient remained infected after 412 days at the last reported follow-up.This unsettling volatility identifies the imperative for greater treatment options and care customization for immunocompromised individuals.What This Means for People With Low Immunity?Tens of millions of individuals across the globe have weakened immune systems—because of organ transplants, autoimmune conditions, or cancer treatments. The results from this study indicate an immediate call to maintain awareness in safeguarding these groups, particularly as pandemic measures loosened and mask mandates are all but gone.This case not only illuminates the biological dynamics of COVID-19 but also serves as a reminder of the human narratives behind pandemic statistics. This patient existed, in a state of health most people shake off in a matter of days or weeks, for almost a year and a half—a grim reminder of the unpredictability of the virus and the strength of its victims.

longest covid infection reported lasted 505 days nonstop; what are persistent infections?

First-Ever Acne Vaccine Enters Clinical Trials; Could Clear Skin Be Just One Shot Away?

first-ever acne vaccine enters clinical trials; could clear skin be just one shot away?

After weeks of uncertainty and regulatory limbo, the U.S. Food and Drug Administration (FDA) has officially approved Novavax's new <span>COVID-19</span> vaccine—taking a significant yet limited step forward in the pandemic-era immunization efforts. Unlike the mRNA vaccines that hogged headlines and big rollouts in the pandemic's first two years, Novavax's shot presents a more conventional protein-based choice. But the green light comes with strings attached: it's only for people aged 65 and above, or above 12 with certain high-risk medical conditions. 

This selective approval has sparked debate in public health communities. While some welcome the approval as long-overdue progress, others decry the restriction placed on public access, particularly in light of surging COVID-19 infections in some parts of Asia and the changing symptomology of newer variants.

The FDA initially established a deadline for the approval of Novavax on April 1, but the target date came and went with no announcement, leaving uncertainty about the future of the shot in the United States vaccine market. The ultimate approval was relayed to Novavax on a Friday evening after what company officials characterized as "substantial back-and-forth" negotiations with regulators. Silvia Taylor, Chief Corporate Affairs and Advocacy Officer for Novavax, said the company was told just before the weekend started.

Adding to the doubt, U.S. Health and Human Services Secretary Robert F. Kennedy Jr.—a self-professed vaccine skeptic—publicly questioned the efficacy of the shot in an interview with CBS. His comments stoked wider public doubts, although most within the scientific community are still convinced of the vaccine's safety and performance record.

<h2>Why is Covid Vaccination Still Important?</h2>

In contrast to the mRNA-based platforms of Pfizer-BioNTech and Moderna, Novavax's vaccine is based on a recombinant protein platform—a technology that is akin to those employed in licensed vaccines such as hepatitis B. This technology could be desirable to those who were resistant to mRNA vaccines because they are worried about newer biotechnology.

Experts indicate that the Novavax vaccine might also be attractive in populations or regions where cold storage demands for mRNA vaccines have presented logistical problems. Yet with limited approval, this advantage won't necessarily come into full play under the existing rollout.

<h2>Who Can Actually Get The New <span rel="noindex">Covid Vaccine</span>?</h2>

The newly approved Novavax vaccine under the brand name Nuvaxovid will only be issued to:

<ul><li>Adults 65 and older</li><li>People aged 12 to 64 years with underlying health conditions</li></ul>

Such conditions, according to the Centers for Disease Control and Prevention (CDC), include asthma, diabetes, obesity, cardiovascular disease, and pregnancy. Behavioral and lifestyle risks like smoking, physical inactivity, and substance abuse also come under this category.

While the wide range of risk factors might limit the decision to many, most in the medical field find the ruling too restrictive. Former FDA Chief Scientist Jesse Goodman criticized the agency's limited approval publicly, saying, "The FDA approval process is intended to determine safety and efficacy, and permit access to approved vaccines. It is not where one makes policy suggestions for use of approved vaccines."

<h2>Worrying Global Spike in COVID-19 Cases</h2>

The green light comes amid a growing COVID resurgence in Southeast Asia. In Singapore, weekly cases rose by 28% as of early May, with hospitalizations per day increasing by almost 30%. In Hong Kong, the rate of respiratory sample positivity exploded from 1.7% in March to more than 11%—above previous peaks during waves. Thailand and China on the mainland have likewise documented parallel trends, with clusters of infections occurring after national holidays and test positivity doubling in the last few weeks. 

The increase in case numbers among elderly people—many with co-existing conditions—harks back to how badly we need vaccine supply to vulnerable groups worldwide.

<h2>What We Know About the 2025 COVID Variants</h2>

The presentation of COVID-19 in the clinical setting continues to change. Although frequently seen symptoms like fever, sore throat, and cough are still prominent, newer strains are bringing back previously uncommon presentations. Anosmia (lack of smell), which was a characteristic of early iterations of COVID and waned during the Omicron surge, is resurfacing, especially in European presentations of the JN.1 variant.

Moreover, Long COVID continues to be a lingering issue. Most patients—barring severity—experience residual symptoms like fatigue, brain fog, and breathing problems. This speaks volumes of the necessity for ongoing vaccination campaigns, even as the virus becomes endemic in large sections of the globe.

While the FDA's authorization of the Novavax vaccine can feel like a specialized addendum in a post-pandemic era, it raises larger questions about public health policy. Should people be able to make their own choices among vaccine options? Are regulatory agencies being overcautious at the cost of personal freedom?

More than three years into the global pandemic, the virus continues to evolve—and so must our approach to prevention. With global case counts on the rise once again, particularly in vulnerable populations, time may reveal whether the FDA’s cautious stance was wise policy—or a missed opportunity.

If you are 65 or older, or have a chronic health problem, talk to your doctor to determine if the new Novavax vaccine is appropriate for you. As with everything related to health, individual risk and expert advice should be considered together.

covid vaccine

novavax covid vaccine

fda nuvaxovid approval

protein-based covid vaccine

new covid vaccine 2025

covid vaccine for seniors

long covid risk

covid-19 global surge

After weeks of uncertainty and regulatory limbo, the U.S. Food and Drug Administration (FDA) has officially approved Novavax's new COVID-19 vaccine—taking a significant yet limited step forward in the pandemic-era immunization efforts. Unlike the mRNA vaccines that hogged headlines and big rollouts in the pandemic's first two years, Novavax's shot presents a more conventional protein-based choice. But the green light comes with strings attached: it's only for people aged 65 and above, or above 12 with certain high-risk medical conditions. This selective approval has sparked debate in public health communities. While some welcome the approval as long-overdue progress, others decry the restriction placed on public access, particularly in light of surging COVID-19 infections in some parts of Asia and the changing symptomology of newer variants.The FDA initially established a deadline for the approval of Novavax on April 1, but the target date came and went with no announcement, leaving uncertainty about the future of the shot in the United States vaccine market. The ultimate approval was relayed to Novavax on a Friday evening after what company officials characterized as "substantial back-and-forth" negotiations with regulators. Silvia Taylor, Chief Corporate Affairs and Advocacy Officer for Novavax, said the company was told just before the weekend started.Adding to the doubt, U.S. Health and Human Services Secretary Robert F. Kennedy Jr.—a self-professed vaccine skeptic—publicly questioned the efficacy of the shot in an interview with CBS. His comments stoked wider public doubts, although most within the scientific community are still convinced of the vaccine's safety and performance record.Why is Covid Vaccination Still Important?In contrast to the mRNA-based platforms of Pfizer-BioNTech and Moderna, Novavax's vaccine is based on a recombinant protein platform—a technology that is akin to those employed in licensed vaccines such as hepatitis B. This technology could be desirable to those who were resistant to mRNA vaccines because they are worried about newer biotechnology.Experts indicate that the Novavax vaccine might also be attractive in populations or regions where cold storage demands for mRNA vaccines have presented logistical problems. Yet with limited approval, this advantage won't necessarily come into full play under the existing rollout.Who Can Actually Get The New Covid Vaccine?The newly approved Novavax vaccine under the brand name Nuvaxovid will only be issued to:Adults 65 and olderPeople aged 12 to 64 years with underlying health conditionsSuch conditions, according to the Centers for Disease Control and Prevention (CDC), include asthma, diabetes, obesity, cardiovascular disease, and pregnancy. Behavioral and lifestyle risks like smoking, physical inactivity, and substance abuse also come under this category.While the wide range of risk factors might limit the decision to many, most in the medical field find the ruling too restrictive. Former FDA Chief Scientist Jesse Goodman criticized the agency's limited approval publicly, saying, "The FDA approval process is intended to determine safety and efficacy, and permit access to approved vaccines. It is not where one makes policy suggestions for use of approved vaccines."Worrying Global Spike in COVID-19 CasesThe green light comes amid a growing COVID resurgence in Southeast Asia. In Singapore, weekly cases rose by 28% as of early May, with hospitalizations per day increasing by almost 30%. In Hong Kong, the rate of respiratory sample positivity exploded from 1.7% in March to more than 11%—above previous peaks during waves. Thailand and China on the mainland have likewise documented parallel trends, with clusters of infections occurring after national holidays and test positivity doubling in the last few weeks. The increase in case numbers among elderly people—many with co-existing conditions—harks back to how badly we need vaccine supply to vulnerable groups worldwide.What We Know About the 2025 COVID VariantsThe presentation of COVID-19 in the clinical setting continues to change. Although frequently seen symptoms like fever, sore throat, and cough are still prominent, newer strains are bringing back previously uncommon presentations. Anosmia (lack of smell), which was a characteristic of early iterations of COVID and waned during the Omicron surge, is resurfacing, especially in European presentations of the JN.1 variant.Moreover, Long COVID continues to be a lingering issue. Most patients—barring severity—experience residual symptoms like fatigue, brain fog, and breathing problems. This speaks volumes of the necessity for ongoing vaccination campaigns, even as the virus becomes endemic in large sections of the globe.While the FDA's authorization of the Novavax vaccine can feel like a specialized addendum in a post-pandemic era, it raises larger questions about public health policy. Should people be able to make their own choices among vaccine options? Are regulatory agencies being overcautious at the cost of personal freedom?More than three years into the global pandemic, the virus continues to evolve—and so must our approach to prevention. With global case counts on the rise once again, particularly in vulnerable populations, time may reveal whether the FDA’s cautious stance was wise policy—or a missed opportunity.If you are 65 or older, or have a chronic health problem, talk to your doctor to determine if the new Novavax vaccine is appropriate for you. As with everything related to health, individual risk and expert advice should be considered together.

Ishita Roy

Covid Cases Surge In Singapore: What Do We Know About The New Variant On The Loose

Covid is again making headlines as Singapore experiences a significance surge in <span>COVID-19</span> cases. The spike has been concerning as the number of cases rose from the week of April 27 to May 3 to 14,200 cases, as compared to 11,100 cases in the last week. 

As per the Ministry of Health, the spike in cases is attributed to the new variant which may be on the loose - LF.7 and NB.1.8. These two are descendants of the JN.1 variant. 

The cases have also spiked in Hong Kong. Thus Hong Kong's Centre for Health Protection (CHP) said that the rising COVID activity reached a 1-year high and have urged people to take precautions and receive an initial dose of COVID vaccine as soon as possible. 

The Ministry of Health, Singapore, informed, ""LF.7 and NB.1.8 are the main Covid-19 variants circulating in Signapore." They are the descendants of the JN.1 variant that is used in COVID-19 vaccines. 

"At precent, LF.7 and NB.1.8 are the main COVID-19 variants circulating in Singapore, together accounting for more than two-thirds of locally sequenced cases. JN.1 is also the variant used in the formulation of the current COVID-19 vaccines," said Ministry in the statement. 

<h4>What Are The Symptoms Of This New Variant?</h4>

The symptoms which are associated with this current Covid wave are a bit different from what we have seen before. While cough and sore throat are there, the symptoms also include nausea, vomiting, brain fog, and conjunctivitis. 

The symptoms however are mild. The experts have for now asked people to monitor their health and seek medical attention in case it is required. 

In Hong Kong, the situation seems serious as the experts have warned that "the virus activity is quite high". As of May 3, 31 deaths were reported among 81 severe Covid cases. 83% of the people infected were those above the age of 65. 

In a press release, the Ministry of Health said, "Individuals at increases risk of severe COVID-19, such as those aged 60 years and above, medically vulnerable individuals or residents of aged care facilities, are recommended to keep updated with vaccinations, i.e. to receive an additional dose around one year after their last dose. Healthcare workers and persons living or working with medically vulnerable individuals are also encouraged to receive the vaccine. Other individuals aged six months and above who wish to receive the COVID-19 vaccine can continue to do so." 

Sewage samples showed a rise in viral load, accompanied by an increase in respiratory samples testing positive for Covid-19. Meanwhile, Thailand’s Department of Disease Control reported two cluster outbreaks in 2025.

The public has also been advised to practice the standard precautions, including mask-wearing in crowded places, regular handwashing, and staying at home when unwell.

As reported in Medical Buyer, Sabine Kapasi, advisor, public health and healthcare services, strategist, United Nations COVID-19 Task Force, said India's Covid situation is relatively stable, with a low number of active cases. "States like Kerala and Tamil Nadu are testing more due to their higher case loads," she noted. 

As per the data from COVID-19 dashboard, more than 85% of new cases, which makes 46 out of 58 cases in India, have come from Tamil Nadu, Kerala, and Puducherry. 

covid 19

travis head covid

covid 19 symptoms 2025

health news

covid news

covid cases in india today

singapore covid

new variant in singapore

new covid  variant

Covid is again making headlines as Singapore experiences a significance surge in COVID-19 cases. The spike has been concerning as the number of cases rose from the week of April 27 to May 3 to 14,200 cases, as compared to 11,100 cases in the last week. As per the Ministry of Health, the spike in cases is attributed to the new variant which may be on the loose - LF.7 and NB.1.8. These two are descendants of the JN.1 variant. The cases have also spiked in Hong Kong. Thus Hong Kong's Centre for Health Protection (CHP) said that the rising COVID activity reached a 1-year high and have urged people to take precautions and receive an initial dose of COVID vaccine as soon as possible. The Ministry of Health, Singapore, informed, ""LF.7 and NB.1.8 are the main Covid-19 variants circulating in Signapore." They are the descendants of the JN.1 variant that is used in COVID-19 vaccines. "At precent, LF.7 and NB.1.8 are the main COVID-19 variants circulating in Singapore, together accounting for more than two-thirds of locally sequenced cases. JN.1 is also the variant used in the formulation of the current COVID-19 vaccines," said Ministry in the statement. What Are The Symptoms Of This New Variant?The symptoms which are associated with this current Covid wave are a bit different from what we have seen before. While cough and sore throat are there, the symptoms also include nausea, vomiting, brain fog, and conjunctivitis. The symptoms however are mild. The experts have for now asked people to monitor their health and seek medical attention in case it is required. In Hong Kong, the situation seems serious as the experts have warned that "the virus activity is quite high". As of May 3, 31 deaths were reported among 81 severe Covid cases. 83% of the people infected were those above the age of 65. In a press release, the Ministry of Health said, "Individuals at increases risk of severe COVID-19, such as those aged 60 years and above, medically vulnerable individuals or residents of aged care facilities, are recommended to keep updated with vaccinations, i.e. to receive an additional dose around one year after their last dose. Healthcare workers and persons living or working with medically vulnerable individuals are also encouraged to receive the vaccine. Other individuals aged six months and above who wish to receive the COVID-19 vaccine can continue to do so." Sewage samples showed a rise in viral load, accompanied by an increase in respiratory samples testing positive for Covid-19. Meanwhile, Thailand’s Department of Disease Control reported two cluster outbreaks in 2025.The public has also been advised to practice the standard precautions, including mask-wearing in crowded places, regular handwashing, and staying at home when unwell.Should India Be Concerned?As reported in Medical Buyer, Sabine Kapasi, advisor, public health and healthcare services, strategist, United Nations COVID-19 Task Force, said India's Covid situation is relatively stable, with a low number of active cases. "States like Kerala and Tamil Nadu are testing more due to their higher case loads," she noted. As per the data from COVID-19 dashboard, more than 85% of new cases, which makes 46 out of 58 cases in India, have come from Tamil Nadu, Kerala, and Puducherry. 

About Us

Contact Us

Terms & Conditions

Privacy Policy

Company

Health and Me is a premium website with content written and curated to function as a handbook for all Health concerns.